St. Jude Medical cops to Durata plant problems
January 9, 2013 by MassDevice staff
St. Jude Medical admits to quality control problems at the plant that makes its Durata defibrillator leads in a letter to the FDA reviewed by the Wall Street Journal and says it's putting procedures in place to remedy the issues.
St. Jude Medical (NYSE:STJ) copped to quality control problems at the Sylmar, Calif., plant that makes its next-generation Durata defibrillator leads, saying it's put measures in place to remedy the issues.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
Navigation
NEWS
Symbios recalls GoPump and GOBlock kits following patient complaints
Symbios Medical Products recalls 2 years' worth of its GoPump systems and GOBlock kits after...
Covidien launches its new respiratory monitoring device
Covidien's MicroStream MicroPod respiratory monitoring module hits the shelves
New Xbox One Kinect game system can measure heartbeat visually | MassDevice.com On Call
The newly unveiled iteration of the Microsoft Xbox One's Kinect camera demonstrates the ability to...
MassDevice.com +3 | The top 3 med-tech stories for May 22, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.
FDA's Ortho Panel supports down-classification of pedicle screw spinal systems
The FDA's Orthopedic & Rehabilitations Devices Panel agrees with the FDA's recommendations that...
